372 related articles for article (PubMed ID: 15695116)
21. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
23. The role of angiogenin in pT1-T2 tongue carcinoma neo-angiogenesis and cell proliferation: an exploratory study.
Marioni G; Staffieri A; Fasanaro E; Stramare R; Giacomelli L; Bernardi E; Val M; Stellini E; de Filippis C; Blandamura S
J Oral Pathol Med; 2013 Sep; 42(8):606-11. PubMed ID: 23432607
[TBL] [Abstract][Full Text] [Related]
24. CD105 expression is an independent predictor of survival in patients with endometrial cancer.
Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O
Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
26. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance.
Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S
World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355
[TBL] [Abstract][Full Text] [Related]
27. [The expressions of TP, MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance].
Liu Y; Xue X; Wang F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Feb; 22(3):100-3. PubMed ID: 18476626
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
29. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development.
Akagi K; Ikeda Y; Sumiyoshi Y; Kimura Y; Kinoshita J; Miyazaki M; Abe T
Surgery; 2002 Jan; 131(1 Suppl):S109-13. PubMed ID: 11821796
[TBL] [Abstract][Full Text] [Related]
30. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
[TBL] [Abstract][Full Text] [Related]
31. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
Wang Y; Zhang XH; Guo P; Yan LN; He D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
[TBL] [Abstract][Full Text] [Related]
32. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
33. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
34. CD105-assessed micro-vessel density is associated with malignancy recurrence in laryngeal squamous cell carcinoma.
Marioni G; Ottaviano G; Giacomelli L; Staffieri C; Casarotti-Todeschini S; Bonandini E; Staffieri A; Blandamura S
Eur J Surg Oncol; 2006 Dec; 32(10):1149-53. PubMed ID: 16979866
[TBL] [Abstract][Full Text] [Related]
35. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
[TBL] [Abstract][Full Text] [Related]
36. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis.
Kumar S; Ghellal A; Li C; Byrne G; Haboubi N; Wang JM; Bundred N
Cancer Res; 1999 Feb; 59(4):856-61. PubMed ID: 10029075
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
38. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
39. Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters.
Lentsch EJ; Goudy S; Sosnowski J; Major S; Bumpous JM
Laryngoscope; 2006 Mar; 116(3):397-400. PubMed ID: 16540897
[TBL] [Abstract][Full Text] [Related]
40. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
Martinović Ž; Kovač D; Martinović C
World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
